Can one AI system meaningfully improve another without going back to expensive retraining runs? In other words, can our ...
The strategy, known as synthetic biology, is gaining momentum globally as a conservation tool and human health solution, ...
We’re hoping to see more early-stage funding in 2026 to help newer companies get off the ground. The public market, especially IPOs, has been a bit slow, with only 11 companies going public in 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results